roflumilast 250 MCG Oral Tablet
- RxCUI
- 2001319
- RxNorm name
- roflumilast 250 MCG Oral Tablet
- Display name
- roflumilast 250 MCG Oral Tablet
- Full name
- roflumilast 250 MCG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Roflumilast | ROFLUMILAST | Jubilant Cadista Pharmaceuticals Inc. | aaa81c1b-f63d-4e61-8bfa-9d42d92043c7 | 2026-07-14 | Warnings, Adverse reactions | 2001319 |
| roflumilast | ROFLUMILAST | AvKARE | 55009549-3f0c-1f58-e063-6294a90a6c03 | 2026-06-24 | Warnings, Adverse reactions | 2001319 |
| ROFLUMILAST | ROFLUMILAST | Amici Pharma Inc. | cb3781ff-5350-4f9a-b247-0b04eb0f2b92 | 2026-05-19 | Warnings, Adverse reactions | 2001319 |
| Roflumilast | ROFLUMILAST | MAJOR PHARMACEUTICALS | c51b80f3-a591-4db9-81b4-b91603e35d7c | 2025-12-04 | Warnings, Adverse reactions | 2001319 |
| ROFLUMILAST | ROFLUMILAST | Micro Labs Limited | dc2a689f-cfa4-4863-9623-a9813dcf86a9 | 2025-07-24 | Warnings, Adverse reactions | 2001319 |
| ROFLUMILAST | ROFLUMILAST | Aurobindo Pharma Limited | 7cb11d48-6bb9-437b-bc7f-382050a2d3e6 | 2025-05-27 | Warnings, Adverse reactions | 2001319 |
| Roflumilast | ROFLUMILAST | Ascend Laboratories, LLC | 93d72a99-64dc-4fde-a5b8-78331fa60787 | 2025-03-13 | Warnings, Adverse reactions | 2001319 |
| Roflumilast | ROFLUMILAST | Novadoz Pharmaceuticals LLC | 4d25f69c-58b7-4e2a-b835-4d0c76a83c7c | 2024-08-27 | Warnings, Adverse reactions | 2001319 |
| Roflumilast | ROFLUMILAST | Zydus Pharmaceuticals USA Inc. | 84145572-f320-4c3f-ab29-bd9f6c18746c | 2024-08-16 | Warnings, Adverse reactions | 2001319 |
| Roflumilast | ROFLUMILAST | Zydus Lifesciences Limited | e87287bd-eae3-46c3-9072-04800aeabf40 | 2024-08-12 | 2001319 | |
| Roflumilast | ROFLUMILAST | Camber Pharmaceuticals, Inc. | f25a0230-3cf6-4366-bebe-0ea5ff8de5ab | 2023-04-28 | Warnings, Adverse reactions | 2001319 |
| Daliresp | ROFLUMILAST | AstraZeneca Pharmaceuticals LP | c9a1d0a8-581f-4f91-a2b8-f419192d0ebf | 2020-03-12 | Warnings, Adverse reactions | 2001319 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c9a1d0a8-581f-4f91-a2b8-f419192d0ebf | roflumilast 0.25 MG Oral Tablet | SCD | 15 | These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 2011 | 20200312 |
| c9a1d0a8-581f-4f91-a2b8-f419192d0ebf | roflumilast 250 MCG Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 2011 | 20200312 |
| c9a1d0a8-581f-4f91-a2b8-f419192d0ebf | roflumilast 250 MCG Oral Tablet | SY | 15 | These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 2011 | 20200312 |
| 78d2644d-b62c-48f5-8407-2adf09bcb144 | roflumilast 250 MCG Oral Tablet | SY | 8 | These highlights do not include all the information needed to use ROFLUMILAST tablets safely and effectively. See full prescribing information for ROFLUMILAST tablets. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260109 |
| 78d2644d-b62c-48f5-8407-2adf09bcb144 | roflumilast 250 MCG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use ROFLUMILAST tablets safely and effectively. See full prescribing information for ROFLUMILAST tablets. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260109 |
| 78d2644d-b62c-48f5-8407-2adf09bcb144 | roflumilast 0.25 MG Oral Tablet | SCD | 8 | These highlights do not include all the information needed to use ROFLUMILAST tablets safely and effectively. See full prescribing information for ROFLUMILAST tablets. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260109 |
| dc2a689f-cfa4-4863-9623-a9813dcf86a9 | roflumilast 250 MCG Oral Tablet | PSN | 6 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250724 |
| dc2a689f-cfa4-4863-9623-a9813dcf86a9 | roflumilast 250 MCG Oral Tablet | SY | 6 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250724 |
| dc2a689f-cfa4-4863-9623-a9813dcf86a9 | roflumilast 0.25 MG Oral Tablet | SCD | 6 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250724 |
| 7cb11d48-6bb9-437b-bc7f-382050a2d3e6 | roflumilast 250 MCG Oral Tablet | PSN | 6 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250527 |
| 7cb11d48-6bb9-437b-bc7f-382050a2d3e6 | roflumilast 0.25 MG Oral Tablet | SCD | 6 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250527 |
| 7cb11d48-6bb9-437b-bc7f-382050a2d3e6 | roflumilast 250 MCG Oral Tablet | SY | 6 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250527 |
| 93d72a99-64dc-4fde-a5b8-78331fa60787 | roflumilast 250 MCG Oral Tablet | SY | 5 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250313 |
| 93d72a99-64dc-4fde-a5b8-78331fa60787 | roflumilast 250 MCG Oral Tablet | PSN | 5 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250313 |
| 93d72a99-64dc-4fde-a5b8-78331fa60787 | roflumilast 0.25 MG Oral Tablet | SCD | 5 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20250313 |
| c51b80f3-a591-4db9-81b4-b91603e35d7c | roflumilast 250 MCG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20251204 |
| c51b80f3-a591-4db9-81b4-b91603e35d7c | roflumilast 0.25 MG Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20251204 |
| c51b80f3-a591-4db9-81b4-b91603e35d7c | roflumilast 250 MCG Oral Tablet | SY | 4 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20251204 |
| e87287bd-eae3-46c3-9072-04800aeabf40 | roflumilast 250 MCG Oral Tablet | PSN | 4 | Roflumilast Tablets, for oral use | 20240812 |
| e87287bd-eae3-46c3-9072-04800aeabf40 | roflumilast 250 MCG Oral Tablet | SY | 4 | Roflumilast Tablets, for oral use | 20240812 |
| e87287bd-eae3-46c3-9072-04800aeabf40 | roflumilast 0.25 MG Oral Tablet | SCD | 4 | Roflumilast Tablets, for oral use | 20240812 |
| 4d25f69c-58b7-4e2a-b835-4d0c76a83c7c | roflumilast 250 MCG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20240827 |
| 4d25f69c-58b7-4e2a-b835-4d0c76a83c7c | roflumilast 250 MCG Oral Tablet | SY | 3 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20240827 |
| 4d25f69c-58b7-4e2a-b835-4d0c76a83c7c | roflumilast 0.25 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20240827 |
| 84145572-f320-4c3f-ab29-bd9f6c18746c | roflumilast 250 MCG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20240816 |
| 84145572-f320-4c3f-ab29-bd9f6c18746c | roflumilast 0.25 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20240816 |
| 84145572-f320-4c3f-ab29-bd9f6c18746c | roflumilast 250 MCG Oral Tablet | SY | 3 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20240816 |
| cb3781ff-5350-4f9a-b247-0b04eb0f2b92 | roflumilast 0.25 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260519 |
| cb3781ff-5350-4f9a-b247-0b04eb0f2b92 | roflumilast 250 MCG Oral Tablet | SY | 2 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260519 |
| cb3781ff-5350-4f9a-b247-0b04eb0f2b92 | roflumilast 250 MCG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260519 |
| f25a0230-3cf6-4366-bebe-0ea5ff8de5ab | roflumilast 0.25 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20230428 |
| f25a0230-3cf6-4366-bebe-0ea5ff8de5ab | roflumilast 250 MCG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20230428 |
| f25a0230-3cf6-4366-bebe-0ea5ff8de5ab | roflumilast 250 MCG Oral Tablet | SY | 2 | These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20230428 |
| aaa81c1b-f63d-4e61-8bfa-9d42d92043c7 | roflumilast 250 MCG Oral Tablet | PSN | 1 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260209 |
| aaa81c1b-f63d-4e61-8bfa-9d42d92043c7 | roflumilast 0.25 MG Oral Tablet | SCD | 1 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260209 |
| aaa81c1b-f63d-4e61-8bfa-9d42d92043c7 | roflumilast 250 MCG Oral Tablet | SY | 1 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 2011 | 20260209 |